Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of an Acne mRNA Vaccine Candidate in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne

NCT07756957 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07756957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07756957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of an Acne mRNA Vaccine Candidate in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 30, 2026
Completion date
February 19, 2029
Enrollment
410 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acne